Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
9541por Wu, Lindsey, Mwesigwa, Julia, Affara, Muna, Bah, Mamadou, Correa, Simon, Hall, Tom, Singh, Susheel K., Beeson, James G., Tetteh, Kevin K. A., Kleinschmidt, Immo, D’Alessandro, Umberto, Drakeley, Chris“…In settings where sub-patent infections are prevalent and fluctuate below the detection limit of polymerase chain reaction (PCR), the presence of short-lived antibodies may indicate recent infectivity, particularly in the dry season when clinical cases are rare. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9542“…D.H.B. and N.G. are listed as inventors on already awarded and still pending US patents, claiming beneficial effects on diminished ovarian reserve and embryo ploidy from dehydroepiandrosterone supplementation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9543“…Baseline prevalence of atrial fibrillation, patent foramen ovale, and arterial stenoses were also similar for non-consensus TIA and classic TIA, although stenoses in the posterior circulation were more frequent with non-consensus TIA (OR 2·21, 95% CI 1·59–3·08; p<0·0001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9544por Panovska-Griffiths, J., Ross, J., Elkhodair, S., Baxter-Derrington, C., Laing, C., Raine, R.“…The three interventions: target the influx of patients at ED (A), reduce the pressure on in-patients’ beds (B) and improve ED processes to improve the flow of patents out from ED (C). METHODS: We collected overcrowding metrics (daily attendances, the proportion of people leaving within 4 h of arrival (four-hours target) and the reduction in overall waiting time) during 01/04/2017–31/05/2020. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9545por Rikken, J F W, Kowalik, C R, Emanuel, M H, Bongers, M Y, Spinder, T, Jansen, F W, Mulders, A G M G J, Padmehr, R, Clark, T J, van Vliet, H A, Stephenson, M D, van der Veen, F, Mol, B W J, van Wely, M, Goddijn, M“…STUDY FUNDING/COMPETING INTEREST(S): There was no study funding. M.H.E. reports a patent on a surgical endoscopic cutting device and process for the removal of tissue from a body cavity licensed to Medtronic, outside the scope of the submitted work. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9546por Liu, Qiao, Dong, Taiwei, Xi, Miaomiao, Gou, Licheng, Bai, Yang, Hou, Lian, Li, Min, Ou, Li, Miao, Feng, Wei, Peifeng“…Tongxinluo capsule (TXLC), as a Chinese patent medicine, has received extensive attention in the treatment of CHD in recent years. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9547por Battiwalla, Minoo, Bachier, Carlos, Bhushan, Vikas, Eckrich, Michael J., Eghtedar, Alireza, Frangoul, Haydar, Kambhampati, Suman, Malik, Shahbaz, McSweeney, Peter A., Pantin, Jeremy, Ramakrishnan, Aravind, Safah, Hana, Shaughnessy, Paul J, Blunk, Betsy, Cox, Tonya, Billups, Rocky, Lemaistre, Charles F.“…McSweeney:Kite, a Gilead Company: Consultancy, Honoraria, Research Funding, Speakers Bureau; Fred Hutchinson: Patents & Royalties; Colorado Blood Cancer Institute: Current Employment. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9548por Tomassetti, Carla, Johnson, Neil P, Petrozza, John, Abrao, Mauricio S, Einarsson, Jon I, Horne, Andrew W, Lee, Ted T M, Missmer, Stacey, Vermeulen, Nathalie, Zondervan, Krina T, Grimbizis, Grigoris, De Wilde, Rudy Leon“…In addition, A.W.H. has a patent Serum biomarker for endometriosis pending. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9549por Vermeulen, Nathalie, Abrao, Mauricio S, Einarsson, Jon I, Horne, Andrew W, Johnson, Neil P, Lee, Ted T M, Missmer, Stacey, Petrozza, John, Tomassetti, Carla, Zondervan, Krina T, Grimbizis, Grigoris, De Wilde, Rudy Leon“…In addition, A.W.H. has a patent Serum biomarker for endometriosis pending. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9550por Bock, Andrew J, Sharma-Kuinkel, Batu K, Ruffin, Felicia, Mohnasky, Michael, Eichenberger, Emily, Maskarinec, Stacey, Fowler, Vance G, Thaden, Joshua“…(Consultant)MedImmune (Consultant, Grant/Research Support)Merck (Grant/Research Support)NIH (Grant/Research Support)Novadigm (Consultant)Novartis (Consultant, Grant/Research Support)Pfizer (Grant/Research Support)Regeneron (Consultant, Grant/Research Support)sepsis diagnostics (Other Financial or Material Support, Pending patent for host gene expression signature diagnostic for sepsis.)Tetraphase (Consultant)Theravance (Consultant, Grant/Research Support, Other Financial or Material Support, Educational fees)Trius (Consultant)UpToDate (Other Financial or Material Support, Royalties)Valanbio (Consultant, Other Financial or Material Support, Stock options)xBiotech (Consultant)…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9551por Zhang, Ying, Liu, Yangyang, Li, Ming, Feng, Shaohua, Li, Xiuyang, Gao, Zezheng, Yang, Yingying, Tong, Xiaolin“…Compared with those diagnosed in 2020, cases in 2021 were characterized as lower rates of initial symptoms (88.9% vs 35.8%, P < 0.001) and concomitant medications ever widely used, eg. antiviral medicine (71.6% vs 43.2%, P < 0.001), antibiotics (61.7% vs 13.7%, P < 0.001) and Chinese patent medicine (76.5% vs 44.2%, P < 0.001). They also waited less time for hospitalization (median: 12 vs 2 days, P < 0.001). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9552por Nickols, Nicholas G., Mi, Zhibao, DeMatt, Ellen, Biswas, Kousick, Clise, Christina E., Huggins, John T., Maraka, Spyridoula, Ambrogini, Elena, Mirsaeidi, Mehdi S., Levin, Ellis R., Becker, Daniel J., Makarov, Danil V., Adorno Febles, Victor, Belligund, Pooja M., Al-Ajam, Mohammad, Muthiah, Muthiah P., Montgomery, Robert B., Robinson, Kyle W., Wong, Yu-Ning, Bedimo, Roger J., Villareal, Reina C., Aguayo, Samuel M., Schoen, Martin W., Goetz, Matthew B., Graber, Christopher J., Bhattacharya, Debika, Soo Hoo, Guy, Orshansky, Greg, Norman, Leslie E., Tran, Samantha, Ghayouri, Leila, Tsai, Sonny, Geelhoed, Michelle, Rettig, Mathew B.“…Similarly, no differences were observed between degarelix and placebo groups in any secondary end points, including inpatient mortality (11 patients [17.7%] vs 6 patients [17.6%]) or all-cause mortality (11 patients [17.7%] vs 7 patents [20.6%]). There were no differences between degarelix and placebo groups in the overall rates of adverse events (13 patients [21.0%] vs 8 patients [23.5%) and serious adverse events (19 patients [30.6%] vs 13 patients [32.4%]), nor unexpected safety concerns. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9553por Yan, Hui, Zhai, Bo, Feng, Ruiling, Wang, Penggao, Zhang, Yaodong, Wang, Yiran, Hou, Yuwei, Zhou, Yang“…RESULTS: A total of 42,814 children were identified as having CHD among 5,071,799 live children; the overall prevalence of CHD was 8.44 per 1,000 live births during 2014–2020; and the three subtypes with the highest prevalence of CHD were atrial septal defect (ASD) (2.75‰), ventricular septal defect (VSD) (2.57‰), and patent foramen ovale (PFO) (1.12‰). The prevalence of CHD was 18.87‰ in the group with BW <1,500 g, 12.84‰ in the group with BW 1,500–2,500 g, 8.24‰ in the group with BW 2,500–4,000 g, and 4.80‰ in the group with BW ≥4,000 g. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9554por Pagliara, Eleonora, Marenchino, Maddalena, Antenucci, Laura, Costantini, Mario, Zoppi, Giacomo, Giacobini, Mario Dante Lucio, Bullone, Michela, Riccio, Barbara, Bertuglia, Andrea“…The proposed IMU system was able to provide FJAs in all limbs using a patented method for sensor calibration and related algorithms. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9555“…Pudilan Xiaoyan oral liquid (PDL), a Chinese patent medicine, commonly treats children with mumps. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9556por Heal, C., Hsu, C.C., Ho, Q.A., Dougherty, S.T., Ansinelli, H., Morrison, C., Gay, C., Xing, J.L., Nguyen, S., Gonzalez, V.J., Stea, B., Robbins, J.R.“…There is limited research investigating barriers to adoption within the oncology setting and COVID-19 impacts on patent willingness to use health technology. Understanding these issues is key to successful development and implementation. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9557por De, Kavita, DeStefano, Michelle S, Shoen, Carolyn, Cynamon, Michael H, Alley, M R K“…Cynamon, MD, AN2: Grant/Research Support|AN2: Grant/Research Support MRK Alley, PhD, ABBOTT LABS: Stocks/Bonds|ABBVIE: Stocks/Bonds|AN2 Therapeutics: Author on epetraborole patent|AN2 Therapeutics: Salary|AN2 Therapeutics: Ownership Interest|AVANOS MED INC: Stocks/Bonds|NABRIVA THERAPEUTICS PLC: Stocks/Bonds|NOVARTIS AG: Stocks/Bonds.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9558por Dong, Ning, Jain, Akriti G, Tan, Elaine S, Ball, Somedeb, Whiting, Junmin, Gaballa, Sameh, Isenalumhe, Leidy, Bello, Celeste, Saeed, Hayder, Shah, Bijal D., Locke, Frederick L., Chavez, Julio C., Lancet, Jeffrey E., Sokol, Lubomir, Pinilla Ibarz, Javier, Giuliano, Anna“…Pinilla Ibarz: AbbVie, Janssen, AstraZeneca, Novartis, TG Therapeutics, Takeda: Consultancy, Other: Advisory; Sellas: Other: ), patents/royalties/other intellectual property; MEI, Sunesis: Research Funding; AbbVie, Janssen, AstraZeneca, Takeda: Speakers Bureau. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9559por Treviño Ronzón, Ernesto“…El argumento a desarrollar es que en algunas sociedades donde la agresión, la victimización y la delincuencia alcanzan niveles altos y constantes, la violencia hace patente su función en la disolución y constitución tanto de estructuras, relaciones, identidades y sujetos, como en la inclusión y exclusión social. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo -
9560“…Smith: Consulting Fee; Self; Horizon Therapeutics plc, Viridian, Lundbeck. Other; Self; US patents covering the use of IGF-1 receptor inhibitors in TED which are held by UCLA and the Lundquist Institute. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto